We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Biotech Collaboration to Promote Animal-Based Cancer Research

By LabMedica International staff writers
Posted on 05 Apr 2015
Print article
Two American biotechnology companies have signed a collaboration agreement that is intended to promote animal-based cancer research and drug development.

The two companies, Taconic Biosciences (Hudson, NY, USA) and Cellaria Biosciences (Boxford, Massachusetts, USA) possess complementary technical expertise that, when combined, will facilitate and improve the utility of patient-derived xenografts (PDXs) in animal models for oncology and cancer drug research. Cellaria is known for the development of novel methodologies for generating cells from patient tumors and will benefit from Taconic’s portfolio of tissue humanized mouse models.

The initial project to be conducted under the collaboration agreement will focus on the creation of breast cancer cell lines from PDX models for which Taconic holds licenses from the University of Utah (Salt Lake City, USA).

“Our scientific collaboration with Cellaria is a prime example of Taconic continually pushing the boundaries of technology to improve the utility of humanized animal models in biomedical research,” said Todd Little, president of corporate development at Taconic Biosciences. “By collaborating with a company that has achieved great success in generating cell lines from patient-derived tumors, Taconic will be able to deliver more predictive tissue humanized models that will improve and accelerate oncology research and drug discovery.”

“Taconic and Cellaria have a shared goal to create relevant tools for cancer,” said David Deems, CEO of Cellaria Biosciences. “The new models created through this collaboration have enormous potential to better define target patient populations and evaluate the efficacy of new therapies.”

Related Links:

Taconic Biosciences
Cellaria Biosciences
University of Utah


New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Automated Blood Typing System
IH-500 NEXT
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
New
Vitamin B12 Test
CHORUS CLIA VIT B12

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.